Skip to main content
. Author manuscript; available in PMC: 2016 Aug 22.
Published in final edited form as: Leukemia. 2016 Feb 22;30(6):1355–1364. doi: 10.1038/leu.2016.35

Figure 5. High affinity FRβ IgG reveals increasing expression of FRβ along myeloid differentiation in healthy hematopoietic cells.

Figure 5

(a) FRβ expression in healthy adult BM. Representative histograms from one donor shown. Data from 3–5 independent donors is displayed to the right for the following populations: (1) CD34+ HSCs (Mean 6.3% FRβ+, n=5). (2) Myeloid progenitors–CD123HICD33(−)CD14(−) (Mean 11.4% FRβ+, n=3), (3) Monocyte precursors–CD123low, CD33+, CD14low (Mean 23.2% FRβ+, n=3), and (4) Mature monocytes–CD123(−), CD33+, CD14HI (Mean 68.0% FRβ+, n=3). (Gray histogram– isotype, black dashed histogram – HA-FRβ IgG). (b) FRβ expression in peripheral blood cells. Upper panels – gating strategy to identify subsets. Lower panels – FRβ expression in indicated subsets. (Gray histogram– isotype, color histograms – HA-FRβ IgG) Red – T cells, Green – B cells, Orange – monocytes, Blue – granulocytes, Purple – NK cells. One representative of 3 independent donors shown. (c) Percent FRβ expression detected in peripheral blood monocytes (n=10) using HA-FRβ IgG (mean=66.6%) or LA-FRβ IgG (mean=15.2%) for flow cytometry. Error bars represent mean ± SEM. BM – bone marrow, HSCs – hematopoietic stem cells, SSC – side scatter, FSC – forward scatter, LA – low affinity FRβ, HA – high affinity FRβ. (*** P < .001)

HHS Vulnerability Disclosure